New FDA-Approved Treatment for RKD

The FDA has approved Gazyva® (obinutuzumab) for adults and children ages 2 and older with idiopathic nephrotic syndrome that began in childhood and is frequently relapsing (FRNS) or steroid-dependent (SDNS). More information coming soon. Please visit our Patient Navigation tool for support.

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Chelsea Andreadis

Senior Manager, Donor Engagement

Chelsea Andreadis brings her talents to NephCure as the Senior Manager of Donor Engagement, where she’s dedicated to making a positive impact on the rare kidney disease community! Before joining the team, Chelsea accumulated eight years of valuable experience at ArtsQuest, a nonprofit based in Bethlehem, Pennsylvania, where she excelled in organizing private events and fostering donor relationships. Driven by her passion for creating unforgettable experiences and nurturing meaningful connections, Chelsea is dedicated to leaving a lasting impression on the communities she serves. Outside of work, you'll find Chelsea caring for her beloved cavapoo puppy, Peach and currently residing in Boston, though her heart will always belong to Philadelphia. In her leisure time, she enjoys spending quality time with loved ones, exploring new destinations around the globe, and immersing herself in the vibrant atmosphere of concerts and events.

Boston, MA

Related News

NEWS

NephCure Celebrates C3G Awareness Day on September 25, 2026

NEWS

NephCure Specialist of the Month: Dr. Rupali Avasare

NEWS

Making History on Capitol Hill: Record Advocates Unite for NephCure’s Largest Hill Day Ever

NEWS

NephCure Specialist of the Month: Dr. Fahad Aziz

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.